Reem D Almutairi1,2, Ivo S Muskens3,4, David J Cote5, Mark D Dijkman3, Vasileios K Kavouridis4, Erin Crocker4, Kholoud Ghazawi1, Marike L D Broekman3,4, Timothy R Smith4, Rania A Mekary1,4, Hasan A Zaidi4. 1. Department of Pharmaceutical Business and Administrative Sciences, MCPHS University, Boston, MA, USA. 2. School of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. 3. Brain Center Rudolf Magnus, Utrecht University Medical Center, Utrecht, The Netherlands. 4. Cushing Neurosurgical Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. 5. Cushing Neurosurgical Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. david_cote@hms.harvard.edu.
Abstract
BACKGROUND: Microscopic transsphenoidal surgery (mTSS) is a well-established method to address adenomas of the pituitary gland. Endoscopic transsphenoidal surgery (eTSS) has become a viable alternative, however. Advocates suggest that the greater illumination, panoramic visualization, and angled endoscopic views afforded by eTSS may allow for higher rates of gross total tumor resection (GTR). The aim of this meta-analysis was to determine the rate of GTR using mTSS and eTSS. METHODS: A meta-analysis of the literature was conducted using PubMed, EMBASE, and Cochrane databases through July 2017 in accordance with PRISMA guidelines. RESULTS: Seventy case series that reported GTR rate in 8257 pituitary adenoma patients were identified. For all pituitary adenomas, eTSS (GTR=74.0%; I2 = 92.1%) was associated with higher GTR as compared to mTSS (GTR=66.4%; I2 = 84.0%) in a fixed-effect model (P-interaction < 0.01). For functioning pituitary adenomas (FPAs) (n = 1170 patients), there was no significant difference in GTR rate between eTSS (GTR=75.8%; I2 = 63.9%) and mTSS (GTR=75.5%; I2 = 79.0%); (P-interaction = 0.92). For nonfunctioning pituitary adenomas (NFPAs) (n = 2655 patients), eTSS (GTR=71.0%; I2 = 86.4%) was associated with higher GTR as compared to mTSS (GTR=60.7%; I2 = 87.5%) in a fixed-effect model (P-interaction < 0.01). None of the associations were significant in a random-effect model (all P-interaction > 0.05). No significant publication bias was identified for any of the outcomes. CONCLUSION: Among patients who were not randomly allocated to either approach, eTSS resulted in a higher rate of GTR as compared to mTSS for all patients and for NFPA patients alone, but only in a fixed-effect model. For FPA, however, eTSS did not seem to offer a significantly higher rate of GTR. These conclusions should be interpreted with caution because of the nature of the included non-comparative studies.
BACKGROUND: Microscopic transsphenoidal surgery (mTSS) is a well-established method to address adenomas of the pituitary gland. Endoscopic transsphenoidal surgery (eTSS) has become a viable alternative, however. Advocates suggest that the greater illumination, panoramic visualization, and angled endoscopic views afforded by eTSS may allow for higher rates of gross total tumor resection (GTR). The aim of this meta-analysis was to determine the rate of GTR using mTSS and eTSS. METHODS: A meta-analysis of the literature was conducted using PubMed, EMBASE, and Cochrane databases through July 2017 in accordance with PRISMA guidelines. RESULTS: Seventy case series that reported GTR rate in 8257 pituitary adenomapatients were identified. For all pituitary adenomas, eTSS (GTR=74.0%; I2 = 92.1%) was associated with higher GTR as compared to mTSS (GTR=66.4%; I2 = 84.0%) in a fixed-effect model (P-interaction < 0.01). For functioning pituitary adenomas (FPAs) (n = 1170 patients), there was no significant difference in GTR rate between eTSS (GTR=75.8%; I2 = 63.9%) and mTSS (GTR=75.5%; I2 = 79.0%); (P-interaction = 0.92). For nonfunctioning pituitary adenomas (NFPAs) (n = 2655 patients), eTSS (GTR=71.0%; I2 = 86.4%) was associated with higher GTR as compared to mTSS (GTR=60.7%; I2 = 87.5%) in a fixed-effect model (P-interaction < 0.01). None of the associations were significant in a random-effect model (all P-interaction > 0.05). No significant publication bias was identified for any of the outcomes. CONCLUSION: Among patients who were not randomly allocated to either approach, eTSS resulted in a higher rate of GTR as compared to mTSS for all patients and for NFPApatients alone, but only in a fixed-effect model. For FPA, however, eTSS did not seem to offer a significantly higher rate of GTR. These conclusions should be interpreted with caution because of the nature of the included non-comparative studies.
Entities:
Keywords:
Endoscopic transsphenoidal surgery; Gross total resection; Meta-analysis; Microscopic transsphenoidal surgery; Pituitary adenoma; Transsphenoidal surgery
Authors: Timothy R DeKlotz; Stanley H Chia; Wenxin Lu; Kepher H Makambi; Edward Aulisi; Ziad Deeb Journal: Laryngoscope Date: 2012-01-17 Impact factor: 3.325
Authors: Jackson A Gondim; Joao Paulo C Almeida; Lucas Alverne F Albuquerque; Michele Schops; Erika Gomes; Tania Ferraz; Wladia Sobreira; Meissa T Kretzmann Journal: Pituitary Date: 2011-06 Impact factor: 4.107
Authors: Atte Karppinen; Leena Kivipelto; Satu Vehkavaara; Elina Ritvonen; Emmi Tikkanen; Riku Kivisaari; Juha Hernesniemi; Kirsi Setälä; Camilla Schalin-Jäntti; Mika Niemelä Journal: World Neurosurg Date: 2015-02-28 Impact factor: 2.104
Authors: Nasrin Fatemi; Joshua R Dusick; Carlos Mattozo; David L McArthur; Pejman Cohan; John Boscardin; Christina Wang; Ronald S Swerdloff; Daniel F Kelly Journal: Neurosurgery Date: 2008-10 Impact factor: 4.654
Authors: Ali Erdem Yildirim; Mert Sahinoglu; Ibrahim Ekici; Emin Cagil; Derya Karaoglu; Haydar Celik; Osman Arıkan Nacar; Ahmed Deniz Belen Journal: World Neurosurg Date: 2015-09-04 Impact factor: 2.104
Authors: Khodayar Goshtasbi; Brandon M Lehrich; Mehdi Abouzari; Arash Abiri; Jack Birkenbeuel; Ming-Ying Lan; Wei-Hsin Wang; Gilbert Cadena; Frank P K Hsu; Edward C Kuan Journal: J Neurosurg Date: 2020-03-13 Impact factor: 5.115
Authors: Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst Journal: Acta Neurochir (Wien) Date: 2020-10-21 Impact factor: 2.216